US FDA May Lose Some Autonomy Under Health Department’s General Counsel Reorg

 
• By Sarah Karlin-Smith
  
person in business suit holding giant magnifying glass looking down at smaller people in business suits.
The new HHS Office of General Counsel reorganization may indicate more micromanagement of the FDA is coming. (Shutterstock)

More from US FDA

More from Legal & IP